
Oryzon to invest eur 20 million to develop new drugs
Catalan Economy
10 Sep 2009
Biotech company oryzon genomics has announced a four-year program to invest eur 20 million in the development of new drugs. oryzon ceo carlos buesa indicated that the company would use the resources to strengthen its research on biomarkers and antibody therapy.
oryzon recently opened its new 2,300-square-meter corporate headquarters in cornellà de llobregat (barcelona), with an investment of eur 2.5 million. the company expects revenue of eur 8 million for its current fiscal year.
source: expansión catalunya, 08/09/09
Related News and Success stories.
-
29 May 2025
University of Barcelona Science Park consolidates growth with €124 million in investment in 2024
-
29 May 2025
Catalonia strengthens economic ties with Japan
-
28 May 2025
Catalonia solidifies its position as Spain's leading technology hub
-
26 May 2025
Catalonia promotes itself as a business investment hub during Catalan Week in Osaka